Dordević Hristina
Medicinski fakultet Novi Sad.
Med Pregl. 2006 Nov-Dec;59(11-12):591-7. doi: 10.2298/mpns0612591d.
Herpes simplex viruses type 1 and 2 (HSV-1 and HSV-2) are alpha herpes viruses. Humans are the only natural host and they can be transmitted through oral or genital secretions. These viruses are ubiquitous all over the world, with different percentage rates. The aims of this paper were to determine the serological response to HSV-1 and HSV-2 infection among pregnant women and women of reproductive age and seroprevalence of HSV-1 and HSV-2 antibodies among pregnant women and women of reproductive age.
A total of 81 serum samples were analyzed. 32 sera were collected from pregnant women, and 49 sera were from non-pregnant women of reproductive age. Serum samples were tested for IgM antibodies to both herpes simplex viruses by use of immunoenzymatic assay (Bioelisa HSV IgM Immunocapture; Biokit, Spain)). Sero-type specific ELISA tests: Bioelisa HSV-1 IgG and Bioelisa HSV-2 IgG (Biokit, Spain) were used for detection of IgG antibodies to HSV-1 and HSV-2, respectively.
Type-common IgM antibodies were found in 6.25% of pregnant women, and in 4.08% of women of reproductive age. Type-specific IgG antibodies to HSV-1 were detected in 68.75% of pregnant women, and in 81.63% of non-pregnant women. The seroprevalence of HSV-1 in our sample was 76.5%. Type-specific IgG antibodies to HSV-2 were detected in 12.5% of pregnant women, and in 12.24% of non-pregnant women of reproductive age. The seroprevalence of HSV-2 in the whole sample was 12.35%.
Most women have antibodies to HSV-1, which is partially protective against HSV-2 infection. The seroprevalence of HSV-2 in our sample is relatively low, and similar to seroprevalence in developed European countries. However, there is a high risk of acquiring primary genital HSV infection during pregnancy. Our sample was small, therefore further investigations are required for valid evaluation of seroprevalence of HSV-1 and HSV-2 in Serbia.
单纯疱疹病毒1型和2型(HSV - 1和HSV - 2)属于α疱疹病毒。人类是其唯一的自然宿主,可通过口腔或生殖器分泌物传播。这些病毒在全球普遍存在,感染率各不相同。本文旨在确定孕妇和育龄妇女对HSV - 1和HSV - 2感染的血清学反应,以及孕妇和育龄妇女中HSV - 1和HSV - 2抗体的血清流行率。
共分析了81份血清样本。其中32份血清来自孕妇,49份血清来自非孕育龄妇女。采用免疫酶法(Bioelisa HSV IgM Immunocapture;西班牙Biokit公司)检测血清样本中针对两种单纯疱疹病毒的IgM抗体。血清型特异性ELISA检测:分别使用Bioelisa HSV - 1 IgG和Bioelisa HSV - 2 IgG(西班牙Biokit公司)检测针对HSV - 1和HSV - 2的IgG抗体。
6.25%的孕妇和4.08%的育龄妇女检测出共同型IgM抗体。68.75%的孕妇和81.63%的非孕妇女检测出针对HSV - 1的型特异性IgG抗体。我们样本中HSV - 1的血清流行率为76.5%。12.5%的孕妇和12.24%的非孕育龄妇女检测出针对HSV - 2的型特异性IgG抗体。整个样本中HSV - 2的血清流行率为12.35%。
大多数女性具有针对HSV - 1的抗体,这对HSV - 2感染有部分保护作用。我们样本中HSV - 2的血清流行率相对较低,与欧洲发达国家的血清流行率相似。然而,孕期发生原发性生殖器HSV感染的风险较高。我们的样本量较小,因此需要进一步研究以有效评估塞尔维亚HSV - 1和HSV - 2的血清流行率。